A variety of drugs for the treatment of glaucoma are currently undergoing clinical trials and are expected to be accepted by major players in the market in the near future. The large pipeline of glaucoma medications is expected to propel growth of the global glaucoma eye drops market in the near future. For instance, in January 2019, Santen Pharmaceutical Co., Ltd. started a clinical trial on drug candidate DE-111A (that is a preservative-free, clear, colorless sterile aqueous ophthalmic solution containing 0.015mg of tafluprost and 5.0mg of timolol in 1mL) for open-angle glaucoma treatment, and ocular hypertension treatment. There were 324 patients in the clinical trial. This clinical trial is now in phase 3 and should be finished by the end of June 2020.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/3984
Moreover, in November 2015, Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd., China, initiated a clinical trial with Levobetaxolol eye drops for treatment of primary open-angle glaucoma and ocular hypertension.
The aim of this research is to determine the safety and efficacy of Levobetaxolol in Chinese glaucoma patients. This research involved 366 glaucoma patients from China. The clinical trial is currently in its third phase, with a completion date of December 2021.
Moreover, in recent years, there have been many advancements in glaucoma treatments. However, large product pipeline for glaucoma treatment is expected to drive growth of the global glaucoma eye drops market in the near future
Key Takeaways of the Glaucoma Eye Drops Market:
- The global glaucoma eye drops market is estimated to register a CAGR around 7.0% over the forecast period (2020-2027) due to the large product pipeline for glaucoma treatment.
- On the basis of drug type, the consumables segment is expected to hold a major revenue share in 2027 due to rising product approvals by regulatory authorities. For instance, in November 2017, Bausch Health, a global eye health company, and Nicox S.A., an international ophthalmic company, announced that the U.S. Food and Drug Administration (FDA) approved the New Drug Application (NDA) for VYZULTA (latanoprostene bunod ophthalmic solution, 0.024%) for glaucoma.
- Key players are dominating in the global glaucoma eye drops market such as Allergan Plc., Merck & Co., Inc., Teva Pharmaceutical Industry, Novartis AG., Pfizer, Inc., Inotek Pharmaceutical, Bausch & Lomb Inc., Mylan N.V., Aerie Pharmaceutical, and Jadran-galenski laboratorij d.d.
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/3984
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Glaucoma Eye Drops Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Glaucoma Eye Drops Industry Impact
Chapter 2 Global Glaucoma Eye Drops Competition by Types, Applications, and Top Regions and Countries
2.1 Global Glaucoma Eye Drops (Volume and Value) by Type
2.3 Global Glaucoma Eye Drops (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Glaucoma Eye Drops Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Glaucoma Eye Drops Market Analysis
Chapter 6 East Asia Glaucoma Eye Drops Market Analysis
Chapter 7 Europe Glaucoma Eye Drops Market Analysis
Chapter 8 South Asia Glaucoma Eye Drops Market Analysis
Chapter 9 Southeast Asia Glaucoma Eye Drops Market Analysis
Chapter 10 Middle East Glaucoma Eye Drops Market Analysis
Chapter 11 Africa Glaucoma Eye Drops Market Analysis
Chapter 12 Oceania Glaucoma Eye Drops Market Analysis
Chapter 13 South America Glaucoma Eye Drops Market Analysis
Chapter 14 Company Profiles and Key Figures in Glaucoma Eye Drops Business
Chapter 15 Global Glaucoma Eye Drops Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
Continued….
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/3984
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837